EyePoint Pharmaceuticals Stock (NASDAQ: EYPT) stock price, news, charts, stock research, profile.
Open | $16.080 |
Close | $16.750 |
Volume / Avg. | 1.244M / 986.213K |
Day Range | 15.650 - 16.760 |
52 Wk Range | 5.670 - 30.990 |
Market Cap | $834.666M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 33 |
Short Interest | 18.73% |
Days to Cover | 10.26 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of EyePoint Pharmaceuticals (NASDAQ: EYPT) through any online brokerage.
Other companies in EyePoint Pharmaceuticals’s space includes: GH Research (NASDAQ:GHRS), SNDL (NASDAQ:SNDL), Verona Pharma (NASDAQ:VRNA), WAVE Life Sciences (NASDAQ:WVE) and Tarsus Pharmaceuticals (NASDAQ:TARS).
The latest price target for EyePoint Pharmaceuticals (NASDAQ: EYPT) was reported by HC Wainwright & Co. on Friday, March 8, 2024. The analyst firm set a price target for 33.00 expecting EYPT to rise to within 12 months (a possible 97.01% upside). 21 analyst firms have reported ratings in the last year.
The stock price for EyePoint Pharmaceuticals (NASDAQ: EYPT) is $16.75 last updated April 26, 2024 at 4:20 PM EDT.
There are no upcoming dividends for EyePoint Pharmaceuticals.
EyePoint Pharmaceuticals’s Q1 earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for EyePoint Pharmaceuticals.
EyePoint Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.